Brief: ImmunoGen Announces Collaboration With Takeda To Develop And Commercialize Elahere In Japan

ImmunoGen

28/08/2023 11:38

Aug 28 (Reuters) - ImmunoGen Inc  IMGN.O :
    * IMMUNOGEN ANNOUNCES COLLABORATION WITH TAKEDA TO DEVELOP
AND
COMMERCIALIZE ELAHERE® IN JAPAN
    * IMMUNOGEN INC - TO RECEIVE $34 MILLION1 IN UPFRONT AND
NEAR-TERM
MILESTONE PAYMENTS
    * IMMUNOGEN INC - ELIGIBLE TO RECEIVE POTENTIAL REGULATORY
AND
COMMERCIAL MILESTONE PAYMENTS AS WELL AS DOUBLE-DIGIT ROYALTIES
    * IMMUNOGEN- UNDER DEAL,CO TO GET ONE-TIME, UPFRONT PAYMENT,
EXTRA
PAYMENT ON CONVERSION OF US FDA ACCELERATED APPROVAL OF ELAHERE
IN PROC TO FULL APPROVAL

Source text for Eikon:  ID:nBw85vQfZa 
Further company coverage:  IMGN.O